Summary: In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed a West Virginia federal court’s ruling that…
Tag:
TECFIDERA
-
-
Diroximel Fumarate
The European Commission Grants Marketing Authorization for VUMERITY® (Diroximel Fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis.
by adminby adminSYNOPSIS: VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy and well-characterized safety, building on Biogen’s…